With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what ...

February is the shortest month, but that doesn't mean income investors don't have much time to find great stocks. Three ...

CPI inflation, retail sales, Jerome Powell congressional testimony, along with earnings from Coca-Cola, McDonald’s, Cisco, ...

This story was originally published by Healthbeat. Sign up for their public health newsletters at healthbeat.org/newsletters.

AbbVie's underlying business remains strong, and so does its dividend program. The company is a Dividend King with 52 ...

This was the stock's second consecutive day of losses.

Georgia has big racial and gender discrepancies in PrEP uptake, said Patrick Sullivan, who is an epidemiology professor at Emory University and leads AIDSVu and PrEPVu, which track HIV data and access ...

Biotech giant Gilead Sciences, Inc. GILD is scheduled to report fourth-quarter and full-year 2024 results on Feb. 11, after ...

Robin Washington joins Salesforce as COFO in March 2025 to lead its transformation in the new agentic era. Congratulations!

We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...